Locally Advanced or Metastatic NRAS Mutant Melanoma
1 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic NRAS Mutant Melanoma
| Record | Firm | Date |
|---|---|---|
| A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma (NCT01781572) | Pfizer | 2013-06-01 |
Track Locally Advanced or Metastatic NRAS Mutant Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.